Latest period
143.58M
YoY change
+6.4%
5Y CAGR
+5.8%
Peak year (2025)
116.17M
Latest annual
116.17M
Shares Outstanding history chart for Tango Therapeutics (TNGX) from 2019 to 2025
Latest: 116.17M
Shares Outstanding growth chart for Tango Therapeutics (TNGX) from 2019 to 2025
Latest: +6.4%
Shares Outstanding history table for Tango Therapeutics (TNGX) from 2019 to 2025
| 2025 | 116.17M | +6.4% | +6.94M | ||
| 2024 | 109.23M | +15.5% | +14.65M | ||
| 2023 | 94.57M | +7.7% | +6.75M | ||
| 2022 | 87.82M | +41.4% | +25.71M | ||
| 2021 | 62.11M | -29.0% | -25.37M | ||
| 2020 | 87.47M | 0.0% | 0 | ||
| 2019 | 87.47M | — | — |
- 2025116.17M+6.4%
- 2024109.23M+15.5%
- 202394.57M+7.7%
- 202287.82M+41.4%
- 202162.11M-29.0%
- 202087.47M0.0%
- 201987.47M—
Shares Outstanding values are taken from Tango Therapeutics's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Shares Outstanding at Tango Therapeutics (TNGX)
According to Tango Therapeutics's latest reported financial statements, the company's latest reported diluted shares outstanding is 143.58M. Diluted weighted-average shares outstanding is the share count used to compute per-share metrics like EPS. Buybacks lower it; new issuance, stock-based compensation, and convertible securities raise it. Multiply by the stock price for market capitalization.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
As of the 2025 fiscal year, Tango Therapeutics (TNGX) reported diluted shares outstanding of 116.17M – grew 6.4% year-over-year.
Through 2020–2025 (5 years), Tango Therapeutics diluted shares outstanding delivered a +5.8% annualised rate; sustaining 4 straight years of year-over-year growth.
116.17M stands as the all-time-high annual diluted shares outstanding, posted in 2025, against a low of 62.11M during 2021.
Tango Therapeutics Shares Outstanding by Year
Tango Therapeutics Shares Outstanding 2025: 116.17M
Tango Therapeutics posted diluted shares outstanding of 116.17M in 2025, grew 6.4% from 2024. This figure represents the highest annual value in the available history.
Tango Therapeutics Shares Outstanding 2024: 109.23M
In 2024, Tango Therapeutics reported diluted shares outstanding of 109.23M, grew 15.5% from 2023.
Tango Therapeutics Shares Outstanding 2023: 94.57M
Tango Therapeutics diluted shares outstanding in 2023 was 94.57M, grew 7.7% from 2022.
Tango Therapeutics Shares Outstanding 2022: 87.82M
2022's diluted shares outstanding for Tango Therapeutics came in at 87.82M, surged 41.4% from 2021.
Tango Therapeutics Shares Outstanding 2021: 62.11M
Tango Therapeutics diluted shares outstanding in 2021 was 62.11M.
See more financial history for Tango Therapeutics (TNGX).
Sector peers by Shares Outstanding
Healthcare peers of Tango Therapeutics (TNGX), ranked by their latest diluted shares outstanding
| 4.45B | |
| 2.51B | |
| 2.43B | |
| 1.77B | |
| 1.56B | |
| 910.00M | |
| 898.00M | |
| 542.00M |
- 4.45B
- 2.51B
- 1.77B
- 1.56B
- 910.00M
- 898.00M
- 542.00M
Frequently asked questions
Tango Therapeutics (TNGX) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation